Alx Oncology Holdings (ALXO) Non-Current Assets (2019 - 2026)

Alx Oncology Holdings (ALXO) has 8 years of Non-Current Assets data on file, last reported at $32.8 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets rose 78.38% year-over-year to $32.8 million; the trailing twelve-month figure through Mar 2026 stood at $67.4 million (down 37.36% YoY), and the FY2025 full-year result was $8.3 million, down 38.02% from the prior year.
• Non-Current Assets rose to $32.8 million in Q1 2026, from $8.3 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $53.9 million in Q4 2023 to a low of $8.3 million in Q4 2025.
• A 5-year average of $29.4 million and a median of $29.2 million in 2022 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets soared 7130.02% in 2022 and plunged 78.08% in 2025, its largest moves.
• Tracing ALXO's Non-Current Assets over 5 years: stood at $35.5 million in 2022, then soared by 51.73% to $53.9 million in 2023, then slumped by 75.09% to $13.4 million in 2024, then sank by 38.02% to $8.3 million in 2025, then jumped by 293.85% to $32.8 million in 2026.
• Business Quant data shows ALXO's Non-Current Assets at $32.8 million in Q1 2026, $8.3 million in Q4 2025, and $16.2 million in Q3 2025.